The estimated Net Worth of Donald E Foley is at least $296 mil dollars as of 6 March 2018. Mr. Foley owns over 25,000 units of Biosig Technologies Inc stock worth over $114,240 and over the last 21 years he sold BSGM stock worth over $0. In addition, he makes $181,881 as Independent Director at Biosig Technologies Inc.
Donald has made over 2 trades of the Biosig Technologies Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 25,000 units of BSGM stock worth $35,500 on 6 March 2018.
The largest trade he's ever made was buying 200,000 units of Biosig Technologies Inc stock on 18 November 2015 worth over $300,000. On average, Donald trades about 8,036 units every 30 days since 2004. As of 6 March 2018 he still owns at least 255,000 units of Biosig Technologies Inc stock.
You can see the complete history of Mr. Foley stock trades at the bottom of the page.
Donald E. Foley serves as Independent Director of the Company. Mr. Foley has served as our director since October 2015. Mr. Foley was chairman of the board and chief executive officer of Wilmington Trust Corporation from 2010-2011. Prior to Wilmington Trust Corporation, Mr. Foley was senior vice president, treasurer and director of tax for ITT Corporation, a supplier of advanced technology products and services. Prior experiences include executive positions with International Paper Company, Mobil Corporation and General Electric Company. Mr. Foley currently serves on the board of directors of AXA Equitable EQAT and Wilmington Trust Mutual Fund Complexes. Mr. Foley also served on the boards of directors of M&T Corporation from 2011-2012 and of Wilmington Trust Company, Wilmington Funds, and Wilmington Trust Corporation from 2007-2011. In addition, Mr. Foley serves as chairman of the board of trustees of the Burke Rehabilitation Hospital and Burke Medical Research Institute, as well as the W. Burke Foundation since 2009 during which time the Hospital merged with the MonteFiore Hospital System. Mr. Foley served as an advisory board member of M&T Corporation Trust and Investment Committee, Goldman Sachs Asset Management Groups and Northern Trust Company. Mr. Foley holds an M.B.A. from New York University, and a B.A. from Union College where he had served as a trustee, and as chairman of the President’s Council. He also served as a trustee of the Covent of the Sacred Heart; and currently serves as a trustee at the Sacred Heart Network of schools and chairman of the board at New Beginning Family Academy, a charter school in Bridgeport, CT. Mr. Foley brings extensive financial, economic, capital markets and executive leadership expertise to our board gained through his successful career on Wall Street and the Fortune 500.
As the Independent Director of Biosig Technologies Inc, the total compensation of Donald Foley at Biosig Technologies Inc is $181,881. There are 9 executives at Biosig Technologies Inc getting paid more, with Kenneth Londoner having the highest compensation of $5,034,850.
Donald Foley is 68, he's been the Independent Director of Biosig Technologies Inc since 2015. There are 1 older and 11 younger executives at Biosig Technologies Inc. The oldest executive at Biosig Technologies Inc is Dr. Budimir S. Drakulic Ph.D., 71, who is the Chief Scientist.
Donald's mailing address filed with the SEC is C/O BIOSIG TECHNOLOGIES, INC., 55 GREENS FARMS ROAD, WESTPORT, CT, 06880.
Over the last 9 years, insiders at Biosig Technologies Inc have traded over $1,778,587 worth of Biosig Technologies Inc stock and bought 1,345,515 units worth $2,296,289 . The most active insiders traders include Kenneth L Londoner, Asher Holzer, eJerome B Zeldis. On average, Biosig Technologies Inc executives and independent directors trade stock every 24 days with the average trade being worth of $11,433. The most recent stock trade was executed by Kenneth L Londoner on 13 June 2023, trading 15,600 units of BSGM stock currently worth $19,344.
biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.
Biosig Technologies Inc executives and other stock owners filed with the SEC include: